SLNCF SILENCE THERAPEUTICS PLC
FollowOrdinary Shares, nominal value 0.05 GBP per share (common), issuer CIK 1479615
No 13F filer reports this security in the loaded quarters.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- Tetragon Financial Management LP (group Tetragon Financial Management LP)
9,878,565 shares, 5.3% in a 13G/A as of 2026-10-05,0000919574-26-006906
Accepted , ingested - FMR LLC(group FMR LLC)
13,180,206 shares, 7.1% in a 13G as of 2026-09-30,0000315066-26-002833
Accepted , ingested - TCG Crossover GP I, LLC (group TCG Crossover GP II, LLC)
5,457,105 shares, 3.9% in a 13G/A as of 2026-09-30,0001193125-26-464018
Accepted , ingested
Insider trades
No Form 4 transaction on this security in the data.
Events
TCG Crossover GP I, LLC and 2 other reporting persons reported 5,457,105 SLNCF shares, 3.9% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-16. 0001193125-26-464018
Accepted , ingestedFMR LLC and 1 other reporting person reported 13,180,206 SLNCF shares, 7.1% of the class, as of 2026-09-30, in a 13G filed 2026-11-05. 0000315066-26-002833
Accepted , ingestedTetragon Financial Management LP and 3 other reporting persons reported 9,878,565 SLNCF shares, 5.3% of the class, as of 2026-10-05, in a 13G/A filed 2026-10-13. 0000919574-26-006906
Accepted , ingestedTetragon Financial Management LP and 3 other reporting persons reported 9,708,153 SLNCF shares, 5.2% of the class, as of 2026-10-05, in a 13G filed 2026-10-13. 0000919574-26-006888
Accepted , ingested